Tdx/Tdxflx & Tdxflx Theophylline Monoclonal II
FDA 510(k) K932127 · Abbott Laboratories
510(k) numberK932127
Submission
- Device name
- Tdx/Tdxflx & Tdxflx Theophylline Monoclonal II
- Applicant
- Abbott Laboratories
Abbott Park, IL, US - Received
- May 3, 1993
- Decision date
- August 9, 1993
- Decision
- Substantially Equivalent (SESE)
- Type
- Traditional 510(k)
- Summary
- 510(k) summary available from FDA
Device classification
- Product code
- LGS – Fluorescence Polarization Immunoassay, Theophylline
- Device class
- Class II (moderate risk)
- Regulation
- 21 CFR 862.3880
- Specialty
- Clinical Toxicology
Other 510(k)s with product code LGS
| 510(k) | Device | Applicant | Decision |
|---|---|---|---|
| K070810 | Architect I Theophylline Reagents and Calibrators (A-F)LGS · Traditional | Biokit, S.A. | 06/08/2007SE |
| K955567 | Innofluor Theophylline Assay SystemLGS · Traditional | Oxis Intl., Inc. | 01/24/1996SE |
| K953016 | Axsym Theophylline IILGS · Traditional | Abbott Laboratories | 08/24/1995SE |
| K951169 | Ciba Corining Acs Theophylline ImmunoassayLGS · Traditional | Ciba Corning Diagnostics Corp. | 06/20/1995SE |
| K942991 | QMS Theophylline CSLGS · Traditional | Seradyn, Inc. | 09/09/1994SE |
| K922991 | Abbott Tdx/Tdxflx and Tdxflx TheophyllineLGS · Traditional | Abbott Laboratories | 08/27/1992SE |
| K900706 | Modified Accufluor Theophylline Reagent & CalibraLGS · Traditional | Innotron of Oregon, Inc. | 04/12/1990SE |
| K894529 | FPR Theophylline KitLGS · Traditional | Colony Laboratories, Inc. | 09/15/1989SE |
| K871484 | Cobas FP Reagents for Theophylline & CalibratorsLGS · Traditional | Roche Diagnostic Systems, Inc. | 05/28/1987SE |
| K870277 | Monitorx Laserx Theophylline Reagent SetLGS · Traditional | American Monitor Corp. | 02/18/1987SE |
More from American Monitor Corp.
| 510(k) | Device | Decision |
|---|---|---|
| K252424 | Anti-HCV NextMZO · Traditional | 04/28/2026SE |
| K243500 | ARCHITECT iGentamicinLCD · Special | 07/09/2025SE |
| K243168 | Alinity i Rubella IgGLFX · Traditional | 06/20/2025SE |
| K243283 | Alinity h-series SystemGKZ · Traditional | 02/20/2025SE |
| K233932 | Alinity i Toxo IgMLGD · Traditional | 08/30/2024SE |
| K232669 | TbiQAT · Special | 09/29/2023SE |
| K222850 | HAVAb IgG IILOL · Traditional | 08/10/2023SE |
| K220031 | Alinity h-series SystemGKZ · Traditional | 08/04/2023SE |
| K220282 | i-STAT PTplus Cartridge with the i-STAT 1 SystemGJS · Traditional | 07/14/2023SE |
| K230937 | Alinity i Total ß-hCG Reagent Kit, GLP systems TrackDHA · Traditional | 06/05/2023SE |
Questions and answers
When was Tdx/Tdxflx & Tdxflx Theophylline Monoclonal II cleared by the FDA?
Tdx/Tdxflx & Tdxflx Theophylline Monoclonal II (K932127) received a 510(k) decision of Substantially Equivalent on August 9, 1993, 98 days after the submission was received.
What is the product code of K932127?
The FDA product code is LGS – Fluorescence Polarization Immunoassay, Theophylline, a Class II (moderate risk) device regulated under 21 CFR 862.3880.